Detalhe da pesquisa
1.
Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma.
Blood
; 128(2): 185-94, 2016 07 14.
Artigo
Inglês
| MEDLINE | ID: mdl-27166360
2.
Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas.
Clin Cancer Res
; 22(9): 2290-300, 2016 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-26647218
3.
Methods for sample acquisition and processing of serial blood and tumor biopsies for multicenter diffuse large B-cell lymphoma clinical trials.
Cancer Epidemiol Biomarkers Prev
; 23(12): 2688-93, 2014 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-25472678
4.
Analysis of genomic abnormalities in tumors: a review of available methods for Illumina two-color SNP genotyping and evaluation of performance.
Cancer Genet
; 206(4): 103-15, 2013 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-23623180
5.
The genomic landscape of TP53 and p53 annotated high grade ovarian serous carcinomas from a defined founder population associated with patient outcome.
PLoS One
; 7(9): e45484, 2012.
Artigo
Inglês
| MEDLINE | ID: mdl-23029043
6.
BRCA mutations and ductal carcinoma in situ.
JAMA
; 294(5): 553-4, 2005 Aug 03.
Artigo
Inglês
| MEDLINE | ID: mdl-16077047